[4-(4-Acetylpiperazin-1-yl)-3-methylphenyl]amine → 3,5-Dichloro-4-(morpholin-4-yl)aniline
反応式
C(N1CCN(C2C=CC(N)=CC=2C)CC1)(=O)C.[Cl:18][C:19]1[CH:24]=[C:23]([N+:25]([O-])=O)[CH:22]=[C:21]([Cl:28])[C:20]=1[N:29]1[CH2:34][CH2:33][O:32][CH2:31][CH2:30]1>>[Cl:28][C:21]1[CH:22]=[C:23]([NH2:25])[CH:24]=[C:19]([Cl:18])[C:20]=1[N:29]1[CH2:30][CH2:31][O:32][CH2:33][CH2:34]1参加物
3
実験手順
Following the general procedure of Intermediate 36 using 4-(2,6-dichloro-4-nitrophenyl)morpholine (prepared as described in J. Med. Chem., 1980, 23(10), 1083) the title compound was obtained; 1H NMR δ 3.01 (4H, t), 3.64 (4H, t), 5.50 (1H, broad s), 6.57 (2H, s); MS m/e MH+ 247.
出典と根拠
- ORDレコード
- ord-c597767fc5df43c4a1ca3e002b1ca0bf
- 出典データセット
- uspto-grants-2010_09
- 特許番号
- US07795283B2
反応ノート
読み込み中…